Cargando…

SLM Produced Porous Titanium Implant Improvements for Enhanced Vascularization and Osteoblast Seeding

To improve well-known titanium implants, pores can be used for increasing bone formation and close bone-implant interface. Selective Laser Melting (SLM) enables the production of any geometry and was used for implant production with 250-µm pore size. The used pore size supports vessel ingrowth, as b...

Descripción completa

Detalles Bibliográficos
Autores principales: Matena, Julia, Petersen, Svea, Gieseke, Matthias, Kampmann, Andreas, Teske, Michael, Beyerbach, Martin, Murua Escobar, Hugo, Haferkamp, Heinz, Gellrich, Nils-Claudius, Nolte, Ingo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425029/
https://www.ncbi.nlm.nih.gov/pubmed/25849656
http://dx.doi.org/10.3390/ijms16047478
_version_ 1782370425885425664
author Matena, Julia
Petersen, Svea
Gieseke, Matthias
Kampmann, Andreas
Teske, Michael
Beyerbach, Martin
Murua Escobar, Hugo
Haferkamp, Heinz
Gellrich, Nils-Claudius
Nolte, Ingo
author_facet Matena, Julia
Petersen, Svea
Gieseke, Matthias
Kampmann, Andreas
Teske, Michael
Beyerbach, Martin
Murua Escobar, Hugo
Haferkamp, Heinz
Gellrich, Nils-Claudius
Nolte, Ingo
author_sort Matena, Julia
collection PubMed
description To improve well-known titanium implants, pores can be used for increasing bone formation and close bone-implant interface. Selective Laser Melting (SLM) enables the production of any geometry and was used for implant production with 250-µm pore size. The used pore size supports vessel ingrowth, as bone formation is strongly dependent on fast vascularization. Additionally, proangiogenic factors promote implant vascularization. To functionalize the titanium with proangiogenic factors, polycaprolactone (PCL) coating can be used. The following proangiogenic factors were examined: vascular endothelial growth factor (VEGF), high mobility group box 1 (HMGB1) and chemokine (C-X-C motif) ligand 12 (CXCL12). As different surfaces lead to different cell reactions, titanium and PCL coating were compared. The growing into the porous titanium structure of primary osteoblasts was examined by cross sections. Primary osteoblasts seeded on the different surfaces were compared using Live Cell Imaging (LCI). Cross sections showed cells had proliferated, but not migrated after seven days. Although the cell count was lower on titanium PCL implants in LCI, the cell count and cell spreading area development showed promising results for titanium PCL implants. HMGB1 showed the highest migration capacity for stimulating the endothelial cell line. Future perspective would be the incorporation of HMGB1 into PCL polymer for the realization of a slow factor release.
format Online
Article
Text
id pubmed-4425029
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-44250292015-05-20 SLM Produced Porous Titanium Implant Improvements for Enhanced Vascularization and Osteoblast Seeding Matena, Julia Petersen, Svea Gieseke, Matthias Kampmann, Andreas Teske, Michael Beyerbach, Martin Murua Escobar, Hugo Haferkamp, Heinz Gellrich, Nils-Claudius Nolte, Ingo Int J Mol Sci Article To improve well-known titanium implants, pores can be used for increasing bone formation and close bone-implant interface. Selective Laser Melting (SLM) enables the production of any geometry and was used for implant production with 250-µm pore size. The used pore size supports vessel ingrowth, as bone formation is strongly dependent on fast vascularization. Additionally, proangiogenic factors promote implant vascularization. To functionalize the titanium with proangiogenic factors, polycaprolactone (PCL) coating can be used. The following proangiogenic factors were examined: vascular endothelial growth factor (VEGF), high mobility group box 1 (HMGB1) and chemokine (C-X-C motif) ligand 12 (CXCL12). As different surfaces lead to different cell reactions, titanium and PCL coating were compared. The growing into the porous titanium structure of primary osteoblasts was examined by cross sections. Primary osteoblasts seeded on the different surfaces were compared using Live Cell Imaging (LCI). Cross sections showed cells had proliferated, but not migrated after seven days. Although the cell count was lower on titanium PCL implants in LCI, the cell count and cell spreading area development showed promising results for titanium PCL implants. HMGB1 showed the highest migration capacity for stimulating the endothelial cell line. Future perspective would be the incorporation of HMGB1 into PCL polymer for the realization of a slow factor release. MDPI 2015-04-02 /pmc/articles/PMC4425029/ /pubmed/25849656 http://dx.doi.org/10.3390/ijms16047478 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Matena, Julia
Petersen, Svea
Gieseke, Matthias
Kampmann, Andreas
Teske, Michael
Beyerbach, Martin
Murua Escobar, Hugo
Haferkamp, Heinz
Gellrich, Nils-Claudius
Nolte, Ingo
SLM Produced Porous Titanium Implant Improvements for Enhanced Vascularization and Osteoblast Seeding
title SLM Produced Porous Titanium Implant Improvements for Enhanced Vascularization and Osteoblast Seeding
title_full SLM Produced Porous Titanium Implant Improvements for Enhanced Vascularization and Osteoblast Seeding
title_fullStr SLM Produced Porous Titanium Implant Improvements for Enhanced Vascularization and Osteoblast Seeding
title_full_unstemmed SLM Produced Porous Titanium Implant Improvements for Enhanced Vascularization and Osteoblast Seeding
title_short SLM Produced Porous Titanium Implant Improvements for Enhanced Vascularization and Osteoblast Seeding
title_sort slm produced porous titanium implant improvements for enhanced vascularization and osteoblast seeding
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425029/
https://www.ncbi.nlm.nih.gov/pubmed/25849656
http://dx.doi.org/10.3390/ijms16047478
work_keys_str_mv AT matenajulia slmproducedporoustitaniumimplantimprovementsforenhancedvascularizationandosteoblastseeding
AT petersensvea slmproducedporoustitaniumimplantimprovementsforenhancedvascularizationandosteoblastseeding
AT giesekematthias slmproducedporoustitaniumimplantimprovementsforenhancedvascularizationandosteoblastseeding
AT kampmannandreas slmproducedporoustitaniumimplantimprovementsforenhancedvascularizationandosteoblastseeding
AT teskemichael slmproducedporoustitaniumimplantimprovementsforenhancedvascularizationandosteoblastseeding
AT beyerbachmartin slmproducedporoustitaniumimplantimprovementsforenhancedvascularizationandosteoblastseeding
AT muruaescobarhugo slmproducedporoustitaniumimplantimprovementsforenhancedvascularizationandosteoblastseeding
AT haferkampheinz slmproducedporoustitaniumimplantimprovementsforenhancedvascularizationandosteoblastseeding
AT gellrichnilsclaudius slmproducedporoustitaniumimplantimprovementsforenhancedvascularizationandosteoblastseeding
AT nolteingo slmproducedporoustitaniumimplantimprovementsforenhancedvascularizationandosteoblastseeding